vericiguat

Ukraine

Drugs containing this active substance

  • VERQUVO

    The drug is indicated for the treatment of symptomatic chronic heart failure in adult patients with reduced ejection fraction who have stabilized after a recent decompensation of heart failure that required intravenous therapy.

    Form: tablets, film-coated

    Active substance Dosage
    vericiguat 2.5 mg

    ATC: C01DX22

    Manufacturer: Bayer AG

  • VERQUVO

    The drug is indicated for the treatment of adult patients with symptomatic chronic heart failure with reduced ejection fraction who have stabilized after a recent exacerbation requiring intravenous therapy.

    Form: tablets, film-coated

    Active substance Dosage
    vericiguat 5 mg

    ATC: C01DX22

    Manufacturer: Bayer AG

  • VERQUVO

    The drug is indicated for the treatment of adults with symptomatic chronic heart failure with reduced ejection fraction who have stabilized after a recent exacerbation of the disease that required intravenous therapy.

    Form: tablets, film-coated

    Active substance Dosage
    vericiguat 10 mg

    ATC: C01DX22

    Manufacturer: Bayer AG